COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,799 Articles (22,527 medRxiv, 8,272 bioRxiv)

Most recent first Previous |  Page 1159: Articles 11581-11590  | Next

The paradox of the COVID-19 pandemic: the impact on patient demand in Japanese hospitals
Ii, M., Watanabe, S.
10.1101/2021.10.01.21264447 — Posted: 2021-10-04
Risk factors for infection, predictors of severe disease and antibody response to COVID-19 in patients with rheumatic diseases in Portugal - a multicentre, nationwide study
Cruz-Machado, A. R., C. Barreira, S., Bandeira, M., Veldhoen, M., Gomes, A., Serrano, M., Duarte, C., Rato, M., Fernandes, B. M., Garcia, S., Pinheiro, F., Bernardes, M., Madeira, N., Miguel, C., Torres, R., Bento Silva, A., Pestana, J., Almeida, D., Mazeda, C., Cunha Santos, F., Pinto, P., Sousa, M., Parente, H., Sequeira, G., Santos, M. J., Fonseca, J. E., C. Romao, V.
10.1101/2021.10.01.21264428 — Posted: 2021-10-03
Initial SARS-CoV-2 viral load is associated with disease severity: a retrospective cohort study
Souverein, D., van Stralen, K., van Lelyveld, S., van Gemeren, C., Haverkort, M., Snijders, D., Soetekouw, R., Kapteijns, E., de Jong, E., Hermanides, G., Aronson, S., Wagemakers, A., Euser, S.
10.1101/2021.10.01.21264412 — Posted: 2021-10-03 Discussion: Onsite
SARS-CoV-2 Seroprevalence among Healthcare Workers
Wiggen, T. D., Bohn, B., Ulrich, A. K., Stovitz, S. D., Strickland, A. J., Naumchik, B. M., Walsh, S., Smith, S., Baumgartner, B., Kline, S., Yendell, S., Hedberg, C., Beebe, T. J., Demmer, R. T.
10.1101/2021.10.02.21264468 — Posted: 2021-10-03 Discussion: Onsite
COVID-19 Neutralizing Antibody Surveillance Testing for Fully Vaccinated Individuals During Delta Variant Spread
Pan, J., Li, Z., Wang, L., Szymanski, J., Romano, M., Yin, D., Wang, A., Small, T., Zou, Z., Li, J., Witham, G., Wang, L., Zhang, Y., Qi, K., Yin, R.
10.1101/2021.10.01.21264371 — Posted: 2021-10-03
Impact of COVID-19 pandemic on diet behaviour among UK adults: a longitudinal analysis of the HEBECO study
Dicken, S. J., Mitchell, J. J., Newberry Le Vay, J., Beard, E., Kale, D., Herbec, A., Shahab, L.
10.1101/2021.10.01.21264008 — Posted: 2021-10-03
Forgoing healthcare during the COVID-19 pandemic in Geneva, Switzerland - a cross-sectional population-based study
Menon, L. K., Richard, V., de Mestral, C., BAYSSON, H. H., Wisniak, A., Guessous, I., Stringhini, S.
10.1101/2021.10.01.21264411 — Posted: 2021-10-03
Recombinant adjuvanted zoster vaccine and reduced risk of COVID-19 diagnosis and hospitalization in older adults
Bruxvoort, K. J., Ackerson, B., Sy, L. S., Bhavsar, A., Tseng, H. F., Florea, A., Luo, Y., Tian, Y., Solano, Z., Widenmaier, R., Shi, M., Van Der Most, R., Schmidt, J. E., Danier, J., Breuer, T., Qian, L.
10.1101/2021.10.01.21264400 — Posted: 2021-10-03
Appearance of IgG to SARS-CoV-2 in saliva effectively indicates seroconversion in mRNA vaccinated immunocompromised individuals
Healy, K., Pin, E., Chen, P., Soderdahl, G., Nowak, P., Mielke, S., Hansson, L., Bergman, P., Smith, E., Ljungman, P., Valentini, D., Blennow, O., Osterborg, A., Gabarrini, G., Almanei, K., Alkharaan, H., Sobkowiak, M., Xu, X., Akbar, M., Lore, K., Hellstrom, C., Muschiol, S., Bogdanovic, G., Buggert, M., Ljunggren, H.-G., Hober, S., Nilsson, P., Sallberg Chen, M.
10.1101/2021.09.30.21264377 — Posted: 2021-10-03
Humoral cross-reactivity towards SARS-CoV-2 in young children with acute respiratory infection with low-pathogenicity coronaviruses
Dhochak, N., Agrawal, T., Shaman, H., Khan, N. A., Kumar, P., Kabra, S. K., Medigeshi, G. R., Lodha, R.
10.1101/2021.10.01.21264349 — Posted: 2021-10-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).